Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Seiwerth, S., Sikiric, P., Grabarevic, Z., et al
Clinical Safety Data : No serious toxicity or increased cancer risk in Phase 2
We have shown that self-report data is a complementary instrument for collecting data regarding treatment response that is qualitatively consistent with medical records, while also enabling collection of information regarding side effects that may not be readily available in EHRs
A.SummersS
5.2 MeSH Pharmacological Classification Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION
US$ 24.08
US$ 21.31
US$ 26.74
